Developing an international pricing strategy for a new
pharmaceutical product is a highly complex, two-step
procedure. It starts with determining the optimal price
in single countries and, based on that, tries to
harmonise prices across countries in such a way that
parallel trade is minimised, potential problems with
pricing. authorities are avoided, and total
profitability across countries is maximised.